Beamtree : Investor Presentation 1HY results and growth strategy focus

onlyuseHalf Year Investor Presentation

March 2022 personalr

Financial Summary 1H FY22

Growth and investment was the focus for the first half of FY22, despite ongoing challenges presented by the
only
COVID-19 pandemic. Thanks to strong revenue performance and excellent customer retention rates, we were able
to make significant investments across the business within our budgeted forecast. Our position remains strong as
we enter the second half of FY22.
use	Strong total revenue​ performance	Recurring revenue
+91% growth in group's revenue and 24% YoY growth exc. acquisitions	Exceeded management forecast
	Net cash of	ARR (annual recurring revenue)
personalCopyright © Beamtree Holdings Limited - All Rights Reserved	1
	Position remains strong	Continued growth YoY
	Operational EBITDA loss of	Customer Renewal
	Investment in headcount for sales, product and technology capabilities	Globally
r

Beamtree has seen continued growth in the first half of FY22

r personal use only

Key acquisition of Potential(x) making Beamtree Australia's largest health data and AI decision support platform.

Ai	Key acquisition of Ainsoff to drive AI product innovation.

100% of our retention and renewal goals for the first half of FY22.

94% increase in staff, due to the integration of Potential(x) and Ainsoff. Beamtree also invested in new skills with 20 new technical staff for product development and go to market professionals in 1H FY22.

We have continued to win major contracts and form strategic partnerships with organisations in Australia and internationally. These include Central Adelaide Local Health Network, Ampath (South Africa), and Southern DHB (NZ).

Building our international program - snapshot of progress

New contract wins in four countries. Groundbreaking strategic partnerships to develop new applications in computer-assisted clinical record coding and remote monitoring of patient deterioration

seu nlyo

Australia

Europe

Saudi Arabia

• Central Adelaide LHN has become the first public hospital to trial implementation of Ainsoff One following clinical trials in Sydney - live trial to start in March
• Queensland Health due to launch Beamtree program in the next month
• UK - Three major NHS hospital trusts to trial auto coding, Ainsoff One, RippleDown® in pathology
• Italy - discussions around potential application of Ainsoff One for elective waiting list management
• Working with Saudi government and hospitals on a second phase of work to improve ongoing coding of clinical records and the secondary uses of this data

		International	• New partnership with Abbott laboratories to significantly expand reach
		• Philips launch RippleDown® as integrated CDS in new LIS
		Diagnostics
ersonalp		• South Africa - Ampath sign for RippleDown®.
	AI decision	• Regional systems and hospital partners plan implementation of breakthrough decision support
	support	applications in Hong Kong and USA.
	Global Health	• Seventeen of the world's leading hospitals agree to build on existing collaboration and participate in
	Comparators	international benchmarking programme.
Copyright © Beamtree Holdings Limited - All Rights Reserved	4
r

Our growth strategy is based on global acceleration in five product and service domains

only
use		Beamtree
	delivers product
		and services
		that enable the
personal		power of data,
	automation and
Copyright © Beamtree Holdings Limited	- All Rights Reserved
		people to
		improve health
		& wellbeing.
r

Diagnostic technology

We enable the efficient and effective delivery of the diagnostic services as they underpin the future of heath and personalised medicine.

Automation, coding and data integrity:

We digitize and automate workflows with data, classification, coding & technical expertise to improve information availability and quality.

Decision support

We bring artificial and human expertise together to enhance decisions that improve care, value and experience.

Analytics and knowledge networks:

Combining data analytics solutions with peer-to-peer alliances that accelerate innovation and knowledge diffusion.

Professional services:

Digital health advisory and research expertise, providing support in service to

our client's success and sustainable impact.

5